| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8f70c5b59b293a0220e30a752bb017f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_670b189efb51f74f08e68cd7279d20d7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 |
| filingDate |
2014-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50ec4f9e35bfb31fbcde38371295ba8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4750dfdd5120e5534e9fe473f7999451 |
| publicationDate |
2018-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CU-24326-B1 |
| titleOfInvention |
PHARMACEUTICAL COMPOSITION THAT INCLUDES AN HMG-Coa REDUCTASA INHIBITOR THAT MINIMIZES THE INTERACTION OF ACETILSALYCLIC ACID WITH STATIN |
| abstract |
<p> The present invention relates to a pharmaceutical composition that includes an HMG-CoA reductase inhibitor, in particular a statin and acetylsalicylic acid so that the interaction of acetylsalicylic acid with the statin is minimized, for prevention or treatment of cardiovascular diseases. </p> |
| priorityDate |
2013-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |